Saving this for later: https://t.co/khN38vxaWh
RT @Neuro_Compass: Review on the sequence of disease-modifying therapies in relapsing #MS to help neurologists make informed treatment deci…
Revisão de acesso livre publicada este mês no Journal of Neurology #springerlink https://t.co/o9G5BOtNxu
Review on the sequence of disease-modifying therapies in relapsing #MS to help neurologists make informed treatment decisions https://t.co/6xnFP1Ddn5
Review to help informed #MS tx decisions, summarising data by DMT & considerations involved through disease course https://t.co/6xnFP1Ddn5
...helping guide treatment decisions in this complex disease: MS. Our article just published https://t.co/5EZZI5D712
I'm reading this on #springerlink https://t.co/5EZZI5D712
How does your neurologist decide which #MS drugs to try next? Here's a guide on DMT drug benefit–risk assessments: https://t.co/31H5HH5A3x https://t.co/NPOvDQGYbT
Modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. #MS #Review https://t.co/kPnHVPFBnY https://t.co/81h2XFL0GW
Helping neurologists to make informed #MS decisions - considerations for treating pts through entire disease course https://t.co/ZfhaD8G3Os
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. https://t.co/XtR6ZNWevG
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. https://t.co/BOyqYr5fCR https://t.co/ihf2F9kNaS